Researchers have pointed out that AML patients with a DNMT3A mutation tend to be M4/M5 subtype [49], and therefore, we have also chosen the human acute monocytic leukemia cell line, THP1, for our studies. The gene discussed is DNMT3A; the disease is acute monocytic leukemia.